Shifting the Focus: Endocrinology-Led Practices for Complication-Centric Management of T2D Through Optimization of GLP-1 RAs and Dual GIP/GLP-1 RAs
Shifting the Focus: Endocrinology-Led Practices for Complication-Centric Management of T2D Through Optimization of GLP-1 RAs and Dual GIP/GLP-1 RAs
Train the Trainer
Type 2 diabetes (T2D) is a major cause of morbidity and mortality that is highly associated with the comorbidities of ASCVD, CKD, and obesity, among others. Despite guideline recommendations, antihyperglycemic agents with cardioprotective benefits continue to be underutilized in patients for whom these therapies are clearly indicated. This can be attributed in part to the complexity of patients coupled with a vast amount of outcomes data, leading to a more complicated decision-making process and persistent clinical inertia.
Faculty: Lee-Shing Chang, MD, Kathleen M. Dungan, MD, MPH
Release Date:
Expiration Date: October 31, 2026